Ward, John H. http://orcid.org/0000-0002-9108-7900
Weir, Elizabeth http://orcid.org/0000-0001-5434-9193
Allison, Carrie http://orcid.org/0000-0003-2272-2090
Baron-Cohen, Simon http://orcid.org/0000-0001-9217-2544
Funding for this research was provided by:
Autism Centre of Excellence at Cambridge (RG72423)
Rosetrees Trust (G102199)
Cambridgeshire and Peterborough NHS Foundation Trust (G102307)
Queen Anne's Gate Foundation
Corbin Charitable Trust
Wellcome Trust (214322\Z\18\Z)
Templeton World Charity Foundation
NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
NIHR Applied Research Collaboration East of England
Innovative Medicines Initiative 2 Joint Undertaking (777394)
SFARI
Article History
Received: 9 May 2023
Accepted: 18 August 2023
First Online: 20 September 2023
Declarations
:
: This study was approved by the University of Cambridge Human Biology Research Ethics Committee (HBREC.2017.28). Explicit consent was obtained by all participants at the start of the survey.
: Not applicable.
: SBC is co-editor-in-chief of Molecular Autism.